A Phase 1/2, First-in-Human, Multicenter, Open-Label Study of SQZ-eAPC-HPV as Monotherapy and in Combination with Immune Checkpoint Inhibitor(s) in Patients with HPV16+ Recurrent, Locally Advanced, or Metastatic Solid Tumors

Is this Study for You?

Let's Get Started!




Histologically confirmed incurable or metastatic solid tumor (including but not limited to cervical and head and neck tumors) that are HPV16+ as determined by histological or HPV16 molecular analysis.

Type of Study



CTRC Inpatient
University of Colorado Hospital

Principal Investigator
Photograph of Antonio Jimeno,  MD, PhD

Antonio Jimeno, MD, PhD

Study ID

Protocol Number: 22-0228

More information available at ClinicalTrials.gov: NCT05357898

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers